Exact(4)
Clinical trials with experimental shots are now underway as experts race to contain an epidemic that has killed more than 6,000 people in west Africa, though there is still uncertainty over how well they will work and how many doses are needed.
To face this growing field, we suggest a strategy that combines prostate-specific antigen (PSA -based clinical trials with exPSA -based human xenograft studies to evaluate potential clinicalventrialsgents for PC.
Patients who had undergone a full-course RT and CHT (i.e., standard RT and concurrent and sequential temozolomide (TMZ) administration) were included in the study, whereas patients enrolled in clinical trials with experimental RT/CHT with antiangiogenetic, anti-EGFR, and any other targeted therapy were excluded.
Using the values of the placebo event rate of 0.11 (9/83) and the paracetamol/codeine event rate of 0.57 (65/114), we simulated 10,000 trials with experimental group size of 114 and a control group size of 83 and counted the proportion in which the simulated NNT was within ± 0.5 of the true NNT of 1.9 [ 11].
Similar(56)
This information, if replicated in other studies, could expand current indications for liver biopsy in patients with L-GVHD, not only to exclude other causes of liver injury, but also to predict clinical outcome, and should be considered in the selection of patients and the design of future trials with new experimental therapies for this complication.
Only pairs of trials with an experimental reliability Γ′ > 0.75 were used in the analysis.
The mixed-model framework implemented accommodates trials with complex experimental designs (including spatial variation), includes derived marker/interval variables, and can include both genetic and nongenetic effects.
In this paper we have proposed a new method for use in phase II trials with several experimental treatments and biomarker subgroups.
Note that here we have only calculated the pairwise type I error rate and power — the issue of familywise error rates for trials with multiple experimental arms is raised in the discussion.
If SARS returns, scientists could mount a clinical trial with an experimental vaccine under emergency conditions.
How astonishing, then, that after the third recurrence, after my oncologist persuaded me to enlist in a trial with an experimental drug, I find myself and my appetites awake.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com